A Genome-Wide siRNA Screen Identifies Novel Phospho-enzymes Affecting Wnt/β-Catenin Signaling in Mouse Embryonic Stem Cells

Stem Cell Reviews and Reports

Volumn 7, Issue 4, 2011, Pages 910-926

  Groenendyk, Jody ^a   Michalak, Marek ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; CATNB PROTEIN, MOUSE; PHOSPHATASE; PHOSPHOTRANSFERASE; SMALL INTERFERING RNA;

ANIMAL; ARTICLE; CELL SURVIVAL; CLUSTER ANALYSIS; CYTOLOGY; EMBRYONIC STEM CELL; GENE EXPRESSION REGULATION; GENE LIBRARY; GENETIC TRANSFECTION; GENETICS; METABOLISM; MOUSE; WNT SIGNALING PATHWAY;

ANIMALS; BETA CATENIN; CELL SURVIVAL; CLUSTER ANALYSIS; EMBRYONIC STEM CELLS; GENE EXPRESSION REGULATION; GENE LIBRARY; MICE; PHOSPHORIC MONOESTER HYDROLASES; PHOSPHOTRANSFERASES; RNA, SMALL INTERFERING; TRANSFECTION; WNT SIGNALING PATHWAY;

EID: 82355182845     PISSN: 15508943     EISSN: 15586804     Source Type: Journal    
DOI: 10.1007/s12015-011-9265-3     Document Type: Article

References (86)

1. Cohen, E. D., Wang, Z., Lepore, J. J., et al. (2007). Wnt/beta-catenin signaling promotes expansion of Isl-1-positive cardiac progenitor cells through regulation of FGF signaling. The Journal of Clinical Investigation, 117, 1794-1804.
2. Zeng, X., Huang, H., Tamai, K., et al. (2008). Initiation of Wnt signaling: control of Wnt coreceptor Lrp6 phosphorylation/activation via frizzled, dishevelled and axin functions. Development, 135, 367-375.
3. Kim, N. G., Xu, C., & Gumbiner, B. M. (2009). Identification of targets of the Wnt pathway destruction complex in addition to beta-catenin. Proceedings of the National Academy of Sciences of the United States of America, 106, 5165-5170.
4. Huber, O., Korn, R., McLaughlin, J., Ohsugi, M., Herrmann, B. G., & Kemler, R. (1996). Nuclear localization of beta-catenin by interaction with transcription factor LEF-1. Mechanisms of Development, 59, 3-10.
5. Eastman, Q., & Grosschedl, R. (1999). Regulation of LEF-1/TCF transcription factors by Wnt and other signals. Current Opinion in Cell Biology, 11, 233-240.
6. Nelson, W. J., & Nusse, R. (2004). Convergence of Wnt, beta-catenin, and cadherin pathways. Science, 303, 1483-1487.
7. Bullions, L. C., & Levine, A. J. (1998). The role of beta-catenin in cell adhesion, signal transduction, and cancer. Current Opinion in Oncology, 10, 81-87.
8. Okita, K., & Yamanaka, S. (2006). Intracellular signaling pathways regulating pluripotency of embryonic stem cells. Current Stem Cell Research & Therapy, 1, 103-111.
9. Hao, J., Li, T. G., Qi, X., Zhao, D. F., & Zhao, G. Q. (2006). WNT/beta-catenin pathway up-regulates Stat3 and converges on LIF to prevent differentiation of mouse embryonic stem cells. Developmental Biology, 290, 81-91.
10. Ogawa, K., Nishinakamura, R., Iwamatsu, Y., Shimosato, D., & Niwa, H. (2006). Synergistic action of Wnt and LIF in maintaining pluripotency of mouse ES cells. Biochemical and Biophysical Research Communications, 343, 159-166.
11. Kleber, M., & Sommer, L. (2004). Wnt signaling and the regulation of stem cell function. Current Opinion in Cell Biology, 16, 681-687.
12. Major, M. B., Roberts, B. S., Berndt, J. D., et al. (2008). New regulators of Wnt/beta-catenin signaling revealed by integrative molecular screening. Science Signaling, 1, ra12.
13. Klapholz-Brown, Z., Walmsley, G. G., Nusse, Y. M., Nusse, R., & Brown, P. O. (2007). Transcriptional program induced by Wnt protein in human fibroblasts suggests mechanisms for cell cooperativity in defining tissue microenvironments. PLoS ONE, 2, e945.
14. James, R. G., Biechele, T. L., Conrad, W. H., et al. (2009). Bruton's tyrosine kinase revealed as a negative regulator of Wnt-beta-catenin signaling. Science Signaling, 2, ra25.
15. 2+ checkpoint in cardiac myofibrillogenesis. The Journal of Cell Biology, 158, 103-113.
16. Tsuji, Y., Yoshimura, N., Aoki, H., et al. (2008). Maintenance of undifferentiated mouse embryonic stem cells in suspension by the serum- and feeder-free defined culture condition. Developmental Dynamics, 237, 2129-2138.
17. Milner, R. E., Baksh, S., Shemanko, C., et al. (1991). Calreticulin, and not calsequestrin, is the major calcium binding protein of smooth muscle sarcoplasmic reticulum and liver endoplasmic reticulum. The Journal of Biological Chemistry, 266, 7155-7165.
18. Parsons, B. D., Schindler, A., Evans, D. H., & Foley, E. (2009). A direct phenotypic comparison of siRNA pools and multiple individual duplexes in a functional assay. PLoS ONE, 4, e8471.
19. Jackson, A. L., Bartz, S. R., Schelter, J., et al. (2003). Expression profiling reveals off-target gene regulation by RNAi. Nature Biotechnology, 21, 635-637.
20. Moon RT. Wnt/beta-catenin pathway. Sci STKE 2005; 271: cm1.
21. Whitehurst, A. W., Bodemann, B. O., Cardenas, J., et al. (2007). Synthetic lethal screen identification of chemosensitizer loci in cancer cells. Nature, 446, 815-819.
22. Barnett, A. G., van der Pols, J. C., & Dobson, A. J. (2005). Regression to the mean: what it is and how to deal with it. International Journal of Epidemiology, 34, 215-220.
23. Loh, Y. H., Wu, Q., Chew, J. L., et al. (2006). The Oct4 and Nanog transcription network regulates pluripotency in mouse embryonic stem cells. Nature Genetics, 38, 431-440.
24. Yamada, G., Kioussi, C., Schubert, F. R., et al. (1994). Regulated expression of Brachyury(T), Nkx1. 1 and Pax genes in embryoid bodies. Biochemical and Biophysical Research Communications, 199, 552-563.
25. Morrison, G. M., & Brickman, J. M. (2006). Conserved roles for Oct4 homologues in maintaining multipotency during early vertebrate development. Development, 133, 2011-2022.
26. Smith, C. I., Islam, T. C., Mattsson, P. T., Mohamed, A. J., Nore, B. F., & Vihinen, M. (2001). The Tec family of cytoplasmic tyrosine kinases: mammalian Btk, Bmx, Itk, Tec, Txk and homologs in other species. Bioessays, 23, 436-446.
27. Readinger, J. A., Mueller, K. L., Venegas, A. M., Horai, R., & Schwartzberg, P. L. (2009). Tec kinases regulate T-lymphocyte development and function: new insights into the roles of Itk and Rlk/Txk. Immunological Reviews, 228, 93-114.
28. Zhang, J., Mruk, D. D., & Cheng, C. Y. (2005). Myotubularin phosphoinositide phosphatases, protein phosphatases, and kinases: their roles in junction dynamics and spermatogenesis. Journal of Cellular Physiology, 204, 470-483.
29. van der Heyden, M. A., Rook, M. B., Hermans, M. M., et al. (1998). Identification of connexin43 as a functional target for Wnt signalling. Journal of Cell Science, 111(Pt 12), 1741-1749.
30. Kikuchi, A. (1999). Roles of Axin in the Wnt signalling pathway. Cellular Signalling, 11, 777-788.
31. Pradeep, A., Sharma, C., Sathyanarayana, P., et al. (2004). Gastrin-mediated activation of cyclin D1 transcription involves beta-catenin and CREB pathways in gastric cancer cells. Oncogene, 23, 3689-3699.
32. Xiuzhu, T., Shore, L., Stram, Y., Michaeli, S. C., Brietbart, H. C., & Shemesh, M. (2003). Duplexes of 21 nucleotide RNA specific for COX II mediates RNA interference in cultured bovine aortic coronary endothelial cells (BAECs). Prostaglandins & Other Lipid Mediators, 71, 119-129.
33. Caunt, C. J., Armstrong, S. P., Rivers, C. A., Norman, M. R., & McArdle, C. A. (2008). Spatiotemporal regulation of ERK2 by dual specificity phosphatases. The Journal of Biological Chemistry, 283, 26612-26623.
34. Nunes-Xavier, C., Roma-Mateo, C., Rios, P., et al. (2011). Dual-specificity MAP kinase phosphatases as targets of cancer treatment. Anticancer Agents in Medicinal Chemistry, 11, 109-132.
35. Lanner, F., & Rossant, J. (2010). The role of FGF/Erk signaling in pluripotent cells. Development, 137, 3351-3360.
36. Cervenka, I., Wolf, J., Masek, J., et al. (2011). Mitogen-activated protein kinases promote WNT/beta-catenin signaling via phosphorylation of LRP6. Molecular and Cellular Biology, 31, 179-189.
37. Kaler P, Godasi BN, Augenlicht L, Klampfer L. The NF-kappaB/AKT-dependent induction of Wnt signaling in colon cancer cells by macrophages and IL-1beta. Cancer Microenviron 2009.
38. Masckauchan, T. N., Shawber, C. J., Funahashi, Y., Li, C. M., & Kitajewski, J. (2005). Wnt/beta-catenin signaling induces proliferation, survival and interleukin-8 in human endothelial cells. Angiogenesis, 8, 43-51.
39. Mulholland, D. J., Dedhar, S., Wu, H., & Nelson, C. C. (2006). PTEN and GSK3beta: key regulators of progression to androgen-independent prostate cancer. Oncogene, 25, 329-337.
40. Hill, R., & Wu, H. (2009). PTEN, stem cells, and cancer stem cells. The Journal of Biological Chemistry, 284, 11755-11759.
41. Yin, Y., & Shen, W. H. (2008). PTEN: a new guardian of the genome. Oncogene, 27, 5443-5453.
42. Mani, M., Lee, S. Y., Lucast, L., et al. (2007). The dual phosphatase activity of synaptojanin1 is required for both efficient synaptic vesicle endocytosis and reavailability at nerve terminals. Neuron, 56, 1004-1018.
43. Blero, D., Payrastre, B., Schurmans, S., & Erneux, C. (2007). Phosphoinositide phosphatases in a network of signalling reactions. Pflugers Arch, 455, 31-44.
44. Robinson, F. L., & Dixon, J. E. (2006). Myotubularin phosphatases: policing 3-phosphoinositides. Trends in Cell Biology, 16, 403-412.
45. Ono, H., Katagiri, H., Funaki, M., et al. (2001). Regulation of phosphoinositide metabolism, Akt phosphorylation, and glucose transport by PTEN (phosphatase and tensin homolog deleted on chromosome 10) in 3T3-L1 adipocytes. Molecular Endocrinology, 15, 1411-1422.
46. Dihlmann, S., Kloor, M., Fallsehr, C., & von Knebel Doeberitz, M. (2005). Regulation of AKT1 expression by beta-catenin/Tcf/Lef signaling in colorectal cancer cells. Carcinogenesis, 26, 1503-1512.
47. Wada, A. (2009). GSK-3 inhibitors and insulin receptor signaling in health, disease, and therapeutics. Frontiers in Bioscience, 14, 1558-1570.
48. Dutta-Simmons, J., Zhang, Y., Gorgun, G., et al. (2009). Aurora kinase A is a target of Wnt/beta-catenin involved in multiple myeloma disease progression. Blood, 114, 2699-2708.
49. Smalley, M. J., & Dale, T. C. (1999). Wnt signalling in mammalian development and cancer. Cancer and Metastasis Reviews, 18, 215-230.
50. Brown, A. M. (2001). Wnt signaling in breast cancer: have we come full circle? Breast Cancer Research, 3, 351-355.
51. Jin, T., George Fantus, I., & Sun, J. (2008). Wnt and beyond Wnt: multiple mechanisms control the transcriptional property of beta-catenin. Cellular Signalling, 20, 1697-1704.
52. Kim, M. K., McGarry, T. J., O Broin, P., Flatow, J. M., Golden, A. A., & Licht, J. D. (2009). An integrated genome screen identifies the Wnt signaling pathway as a major target of WT1. Proceedings of the National Academy of Sciences of the United States of America, 106, 11154-11159.
53. Corbin, M., de Reynies, A., Rickman, D. S., et al. (2009). WNT/beta-catenin pathway activation in Wilms tumors: a unifying mechanism with multiple entries? Genes, Chromosomes & Cancer, 48, 816-827.
54. Reya, T. (2003). Regulation of hematopoietic stem cell self-renewal. Recent Progress in Hormone Research, 58, 283-295.
55. Sato, N., Meijer, L., Skaltsounis, L., Greengard, P., & Brivanlou, A. H. (2004). Maintenance of pluripotency in human and mouse embryonic stem cells through activation of Wnt signaling by a pharmacological GSK-3-specific inhibitor. Natural Medicines, 10, 55-63.
56. Paling, N. R., Wheadon, H., Bone, H. K., & Welham, M. J. (2004). Regulation of embryonic stem cell self-renewal by phosphoinositide 3-kinase-dependent signaling. The Journal of Biological Chemistry, 279, 48063-48070.
57. Watanabe, S., Umehara, H., Murayama, K., Okabe, M., Kimura, T., & Nakano, T. (2006). Activation of Akt signaling is sufficient to maintain pluripotency in mouse and primate embryonic stem cells. Oncogene, 25, 2697-2707.
58. Macurek, L., Lindqvist, A., Lim, D., et al. (2008). Polo-like kinase-1 is activated by aurora A to promote checkpoint recovery. Nature, 455, 119-123.
59. Dutertre, S., Descamps, S., & Prigent, C. (2002). On the role of aurora-A in centrosome function. Oncogene, 21, 6175-6183.
60. Bischoff, J. R., Anderson, L., Zhu, Y., et al. (1998). A homologue of Drosophila aurora kinase is oncogenic and amplified in human colorectal cancers. The EMBO Journal, 17, 3052-3065.
61. Amabile, G., D'Alise, A. M., Iovino, M., et al. (2009). The Aurora B kinase activity is required for the maintenance of the differentiated state of murine myoblasts. Cell Death and Differentiation, 16, 321-330.
62. Beard, E., & Braissant, O. (2010). Synthesis and transport of creatine in the CNS: importance for cerebral functions. Journal of Neurochemistry, 115, 297-313.
63. Kuiper, J. W., van Horssen, R., Oerlemans, F., et al. (2009). Local ATP generation by brain-type creatine kinase (CK-B) facilitates cell motility. PLoS ONE, 4, e5030.
64. Lowik, C. W., & van Bezooijen, R. L. (2006). Wnt signaling is involved in the inhibitory action of sclerostin on BMP-stimulated bone formation. Journal of Musculoskeletal & Neuronal Interactions, 6, 357.
65. Pederson, L., Ruan, M., Westendorf, J. J., Khosla, S., & Oursler, M. J. (2008). Regulation of bone formation by osteoclasts involves Wnt/BMP signaling and the chemokine sphingosine-1-phosphate. Proceedings of the National Academy of Sciences of the United States of America, 105, 20764-20769.
66. Streck, E. L., Amboni, G., Scaini, G., et al. (2008). Brain creatine kinase activity in an animal model of mania. Life Sciences, 82, 424-429.
67. Anton, R., Kestler, H. A., & Kuhl, M. (2007). Beta-catenin signaling contributes to stemness and regulates early differentiation in murine embryonic stem cells. FEBS Letters, 581, 5247-5254.
68. Hirsch, C., Campano, L. M., Wohrle, S., & Hecht, A. (2007). Canonical Wnt signaling transiently stimulates proliferation and enhances neurogenesis in neonatal neural progenitor cultures. Experimental Cell Research, 313, 572-587.
69. Mano, H. (1999). Tec family of protein-tyrosine kinases: an overview of their structure and function. Cytokine & Growth Factor Reviews, 10, 267-280.
70. Apte, U., Zeng, G., Thompson, M. D., et al. (2007). beta-Catenin is critical for early postnatal liver growth. American Journal of Physiology. Gastrointestinal and Liver Physiology, 292, G1578-G1585.
71. Apte, U., Zeng, G., Muller, P., et al. (2006). Activation of Wnt/beta-catenin pathway during hepatocyte growth factor-induced hepatomegaly in mice. Hepatology, 44, 992-1002.
72. Austin, T. W., Solar, G. P., Ziegler, F. C., Liem, L., & Matthews, W. (1997). A role for the Wnt gene family in hematopoiesis: expansion of multilineage progenitor cells. Blood, 89, 3624-3635.
73. de La Coste, A., Romagnolo, B., Billuart, P., et al. (1998). Somatic mutations of the beta-catenin gene are frequent in mouse and human hepatocellular carcinomas. Proceedings of the National Academy of Sciences of the United States of America, 95, 8847-8851.
74. Storm, M. P., Kumpfmueller, B., Thompson, B., et al. (2009). Characterization of the phosphoinositide 3-kinase-dependent transcriptome in murine embryonic stem cells: identification of novel regulators of pluripotency. Stem Cells, 27, 764-775.
75. Wu, D., Pang, Y., Ke, Y., et al. (2009). A conserved mechanism for control of human and mouse embryonic stem cell pluripotency and differentiation by shp2 tyrosine phosphatase. PLoS ONE, 4, e4914.
76. Chan, R. J., Johnson, S. A., Li, Y., Yoder, M. C., & Feng, G. S. (2003). A definitive role of Shp-2 tyrosine phosphatase in mediating embryonic stem cell differentiation and hematopoiesis. Blood, 102, 2074-2080.
77. Qu, C. K., Shi, Z. Q., Shen, R., Tsai, F. Y., Orkin, S. H., & Feng, G. S. (1997). A deletion mutation in the SH2-N domain of Shp-2 severely suppresses hematopoietic cell development. Molecular and Cellular Biology, 17, 5499-5507.
78. Hart, M. J., de los Santos, R., Albert, I. N., Rubinfeld, B., & Polakis, P. (1998). Downregulation of beta-catenin by human Axin and its association with the APC tumor suppressor, beta-catenin and GSK3 beta. Current Biology, 8, 573-581.
79. Polakis, P. (2000). Wnt signaling and cancer. Genes & Development, 14, 1837-1851.
80. Gotz, J., & Schild, A. (2003). Transgenic and knockout models of PP2A. Methods Enzymol, 366, 390-403.
81. Hernandez, M. V., Wehrendt, D. P., & Arregui, C. O. (2010). The protein tyrosine phosphatase PTP1B is required for efficient delivery of N-cadherin to the cell surface. Molecular Biology of the Cell, 21, 1387-1397.
82. Guo, W., Lasky, J. L., Chang, C. J., et al. (2008). Multi-genetic events collaboratively contribute to Pten-null leukaemia stem-cell formation. Nature, 453, 529-533.
83. Larsen, M., Tremblay, M. L., & Yamada, K. M. (2003). Phosphatases in cell-matrix adhesion and migration. Nature Reviews. Molecular Cell Biology, 4, 700-711.
84. Zhang, J., Wong, C. H., Xia, W., et al. (2005). Regulation of Sertoli-germ cell adherens junction dynamics via changes in protein-protein interactions of the N-cadherin-beta-catenin protein complex which are possibly mediated by c-Src and myotubularin-related protein 2: an in vivo study using an androgen suppression model. Endocrinology, 146, 1268-1284.
85. Laporte, J., Bedez, F., Bolino, A., & Mandel, J. L. (2003). Myotubularins, a large disease-associated family of cooperating catalytically active and inactive phosphoinositides phosphatases. Human Molecular Genetics, 12(Spec No 2), 285-292.
86. Blitzer, J. T., & Nusse, R. (2006). A critical role for endocytosis in Wnt signaling. BMC Cell Biology, 7, 28.